Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7999644 | 1.00 | CHRNB2 (0.34) | CHRNB2CHRNA4 | |
| SCHEMBL7999647 | 1.00 | CHRNB2 (0.34) | CHRNB2CHRNA4 | |
| SCHEMBL9046412 | 0.82 | CHRNB2 (0.33) | CHRNB2CHRNA4 | |
| SCHEMBL9046408 | 0.82 | CHRNB2 (0.33) | CHRNB2CHRNA4 | |
| SCHEMBL9029902 | 0.79 | CHRNB2 (0.33) | CHRNB2CHRNA4 | |
| SCHEMBL9029895 | 0.79 | CHRNB2 (0.33) | CHRNB2CHRNA4 | |
| SCHEMBL9837326 | 0.77 | CHRNB2 (0.31) | CHRNB2CHRNA4 | |
| SCHEMBL7982094 | 0.77 | MAPT (0.41) | CHRNB2CHRNA4 | |
| SCHEMBL7982091 | 0.77 | MAPT (0.41) | CHRNB2CHRNA4 | |
| SCHEMBL3226313 | 0.77 | MAPT (0.41) | CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7278140-A | — | — | None | — | — | JP | disclosed |
| US-8293733-B2 | Oil dispersions of nAChR binding neonicotinoids | GAT MICROENCAPSULATION AG (AT) | 2012-10-23 | — | — | US | disclosed |
| US-20120004104-A1 | OIL DISPERSIONS OF nAChR BINDING NEONICOTINOIDS | GAT MICROENCAPSULATION AG (AT) | 2012-01-05 | — | — | US | disclosed |
| JP-H07278140-A | INTERMEDIATE FOR PRODUCING INSECTICIDAL NITROIMINO OR CYANOIMINO COMPOUND | NIPPON BAYERAGROCHEM KK | 1995-10-24 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004104-A1 | OIL DISPERSIONS OF nAChR BINDING NEONICOTINOIDS | CHRND, ITGAM, CHRM2 | CHRNB2 21/4885CHRNA4 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.